Rege Nephro, a Japanese clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicine and drug discovery, has closed a financing round totalling approximately US$10.6 million. Through the issuance of Japan-Keep It Simple Security (J-KISS) share acquisition rights, proceeds are expected to support commercialisation activities for RN-014, the company’s lead… Read More
Kidswell Bio and Treehill Partners have announced the creation of a new US based regenerative medicine company, Kidswell USA. The companies say Kidswell USA will be formed for the purpose of accelerating the development of Kidswell’s cell therapy pipeline, currently targeting cerebral palsy (CP) as a lead… Read More
The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices. Read More
This eBook, sponsored by ThinkCyte, examines the latest advances in the sector and the market potential for regenerative medicine.
NurExone Biologics has been named a finalist in Falling Walls Venture 2025, a global platform that showcases the world’s most promising science-based start-ups. With plans to move into clinical trials next year with an exosome therapy for spinal cord injuries, Diana Turner caught up Dr Lior Shaltiel, CEO… Read More
Cancer is no longer seen as a simple disease of unchecked cell growth, but as a complex, adaptive ecosystem shaped by genetic mutations, immune evasion, and transcriptional plasticity that allow tumours to survive and evolve. Steve Pollard, CSO & Founder of Trogenix and Professor of Stem Cell and Cancer Biology,… Read More
Longeveron has completed enrolment for its Phase IIb clinical trial (ELPIS II) evaluating cellular therapy laromestrocel as a potential adjunct treatment for Hypoplastic Left Heart Syndrome (HLHS). Laromestrocel is a scalable, allogeneic cellular therapy being evaluated in multiple indications. Top-line trial results are anticipated in… Read More
Australian researchers have patented a new microfluidics tool that produces ‘smart’ microgel droplets for exploring regenerative medicines. The platform was created by Dr Ruirui Qiao and her team at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN). Dr Qiao said her team’s UQ-Surf microfludics platform… Read More
Nathan Yee, Senior Director of CMC Portfolio Strategy at Tune Therapeutics, and Lucas Thompson, Senior Director of Research at Tune Therapeutics, discuss the opportunities and challenges in cell therapy. Cell therapy is a transformative medical approach that harnesses living cells as therapeutic agents and has demonstrated the potential to address… Read More
A new study has revealed that reducing the activity of a particular gene using CRISPR gene editing can rejuvenate stem cells in the brain to create fresh neurons. The finding in mice could open new avenues for potential therapeutics to improve brain function and reduce regenerative… Read More
Recently, the Novo Nordisk Foundation updated its strategy to include regenerative medicine. While regenerative medicine is not new to the Foundation, it is now an explicit part of the company’s strategy. DDW’s Megan Thomas caught up with Martin Ridderstråle, Senior Vice President and Head of Medical Science at the… Read More
Spinogenix has initiated a Phase II trial to evaluate SPG302 for the treatment of adult participants with mild-to-moderate Alzheimer’s disease (AD), following approval for the trail in Australia. The study will assess the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical efficacy of SPG302 in adult AD participants. Read More
A class of molecules playing a crucial role in the regulation of gene expression and other cellular processes can restore normal skin structure rather than producing a scar, a University of Manchester-led study suggests. The new findings show that microRNA-29s, a class of small RNAs, could… Read More
New research has brought stem cell transplantation without immune suppression closer to reality. Researchers at the University of Arizona Health Sciences say they are one step closer to understanding immunological rejection, a barrier to regenerative medicine, after genetically modifying pluripotent stem cells to evade immune recognition. Read More
Longevity biotech clock.bio has launched with $4 million in funding to develop regenerative medicines to prevent and treat age-related diseases. The company says its immediate objective is to decode all rejuvenation programmes present in human cells, to build an atlas of disease and rejuvenation targets for… Read More
DDW’s Reece Armstrong speaks to Hendrik Streefkerk, Chief Medical Officer and Drug Safety Officer of CellProthera about the company’s cell therapy for acute myocardial infarction (AMI) and why regenerative medicine could be key to treating cardiac diseases. Based in France, CellProthera is a small, regenerative cell… Read More
